A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
This study has been completed.
Sponsor:
MethylGene Inc.
Information provided by:
MethylGene Inc.
ClinicalTrials.gov Identifier:
NCT00324194
First received: May 8, 2006
Last updated: April 28, 2011
Last verified: May 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2008 |
| Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |